InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,660.00
(
0.33%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.17
(
0.26%
)
Bitcoin
62,910.07
(
-0.22%
)
Post# of 3283
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

antihama

Send PM Follow Ignore
Followers 52
Posts 3352
Boards Moderated 0
Alias Born 10/26/2013

antihama

Re: antihama post# 2676

Friday, 10/18/2019 8:31:26 AM

Friday, October 18, 2019 8:31:26 AM

Post# of 3283
While a TDM-1 Pozi Combo trial bodes well for a HER2 exon 20 mutation trial, I need to walk back what I said regarding the same for EGFR exon 20 mutations since TDM-1 affects HER2 and I don't have any data showing it affects EGFR. However, the idea of doing a pozi P3 combo trial for EGFR exon 20 mutations is valid, I'm sure there's strong candidates for the EGFR pozi combo trial, Cetuximab (post 2546) comes to mind.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent SPPI News
More SPPI News
InvestorsHub NewsWire

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

Start posting your company's news
Only $200 per official company press release!